Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballari Brahmachari

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Indian Journal of Pharmacology|November 25, 2015
Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factorsBallari Brahmachari, Suparna Chatterjee
Clinical Rheumatology|July 15, 2009
Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trialBallari Brahmachari, Suparna Chatterjee, Alakendu Ghosh
Indian Journal of Pharmacology|May 17, 2011
Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational studyBallari Brahmachari, Avijit Hazra, Anup Majumdar
Perspectives in Clinical Research|July 7, 2011
Pharmacovigilance for clinical trials in India: Current practice and areas for reformBallari Brahmachari, Melanie Fernandes, Arun Bhatt
Osteoarthritis and Cartilage|April 25, 2025
Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trialThomas J Schnitzer, Xavier Chevalier, Helene Rovsing, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Indian Journal of Pharmacology|November 25, 2015
Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factorsBallari Brahmachari, Suparna Chatterjee
Clinical Rheumatology|July 15, 2009
Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trialBallari Brahmachari, Suparna Chatterjee, Alakendu Ghosh
Indian Journal of Pharmacology|May 17, 2011
Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational studyBallari Brahmachari, Avijit Hazra, Anup Majumdar
Perspectives in Clinical Research|July 7, 2011
Pharmacovigilance for clinical trials in India: Current practice and areas for reformBallari Brahmachari, Melanie Fernandes, Arun Bhatt
Osteoarthritis and Cartilage|April 25, 2025
Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trialThomas J Schnitzer, Xavier Chevalier, Helene Rovsing, et al.
Pageof 1